ProBioGen's GlymaxX(R) ADCC Enhancement Technology Used by Betta Pharmaceuticals - Markets Insider

ProBioGen's GlymaxX(R) ADCC Enhancement Technology Used by Betta Pharmaceuticals  Markets InsiderBERLIN, Jan. 3, 2019 /PRNewswire/ -- Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® TechnologyProBioGen AG, a premier *service* ...